Charles River Laboratories International (CRL) Total Current Liabilities (2016 - 2025)
Charles River Laboratories International has reported Total Current Liabilities over the past 17 years, most recently at $1.1 billion for Q4 2025.
- Quarterly results put Total Current Liabilities at $1.1 billion for Q4 2025, up 12.7% from a year ago — trailing twelve months through Dec 2025 was $1.1 billion (up 12.7% YoY), and the annual figure for FY2025 was $1.1 billion, up 12.7%.
- Total Current Liabilities for Q4 2025 was $1.1 billion at Charles River Laboratories International, roughly flat from $1.1 billion in the prior quarter.
- Over the last five years, Total Current Liabilities for CRL hit a ceiling of $1.1 billion in Q3 2025 and a floor of $803.4 million in Q1 2021.
- Median Total Current Liabilities over the past 5 years was $1.0 billion (2023), compared with a mean of $1.0 billion.
- Biggest five-year swings in Total Current Liabilities: rose 27.7% in 2021 and later decreased 5.96% in 2024.
- Charles River Laboratories International's Total Current Liabilities stood at $1.0 billion in 2021, then grew by 5.65% to $1.1 billion in 2022, then dropped by 3.34% to $1.1 billion in 2023, then dropped by 5.78% to $994.1 million in 2024, then rose by 12.7% to $1.1 billion in 2025.
- The last three reported values for Total Current Liabilities were $1.1 billion (Q4 2025), $1.1 billion (Q3 2025), and $1.1 billion (Q2 2025) per Business Quant data.